"10.1371_journal.pone.0066127","plos one","2013-06-18T00:00:00Z","Alessandra Solari; Andrea Giordano; Jurgen Kasper; Jelena Drulovic; An van Nunen; Liina Vahter; Frederique Viala; Erika Pietrolongo; Maura Pugliatti; Carlo Antozzi; Davide Radice; Sascha Köpke; Christoph Heesen; on behalf of the AutoMS project","Unit of Neuroepidemiology, Foundation Istituto Di Ricovero e Cura a Carattere Scientifico Neurological Institute C. Besta, Milan, Italy; Department of Primary Medical Care, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Institute of Neurology, School of Medicine, University of Belgrade, Belgrade, Serbia; National MS-Centrum, Melsbroek, Belgium; Department of Neurology, West-Tallinn Central Hospital, Tallinn, Estonia; Department of Neurology, Purpan University Hospital, Toulouse, France; Department of Neuroscience and Imaging, University G. dAnnunzio of Chieti-Pescara, Chieti, Italy; Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy; Department of Neuromuscular Diseases, Foundation Istituto Di Ricovero e Cura a Carattere Scientifico Neurological Institute C. Besta, Milan, Italy; Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Nursing Research Group, Institute of Social Medicine, University of Lübeck, Lübeck, Germany; Institute for Neuroimmunology and Clinical MS Research (inims), University Medical Center Hamburg-Eppendorf, Hamburg, Germany","Conceived and designed the experiments: AS AG JK SK CH. Performed the experiments: AG JK JD AVN FV LV EP MP CA CH. Analyzed the data: AS AG DR JK SK CH. Wrote the paper: AS AG JK SK CH. Revised the manuscript: AS AG JK JD AVN LV FV EP MP CA DR SK CH.","AS was a board member for Biogen Idec and Novartis, and has received speaker honoraria from Genzyme and Merck Serono. JD has received honoraria for consultancy from Bayer Healthcare Pharmaceuticals, and spekers fees from Novartis and Ritchter Gedeon. AL was a board member for Bayer Schering, Biogen Idec, and Merck Serono; she has received travel grants and honoraria from Bayer Schering, Biogen Idec, Merck Serono, Novartis, Sanofi Aventis and Teva. MP has received speaker honoraria from Sanofi Aventis, and travel support from Biogen Idec, Merck-Serono, Novartis, Sanofi Aventis and Teva. CH has received financial support from Bayer Schering, Biogen Idec, Merck Serono and Teva. All other authors declare that they have no conflicts of interest. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.",NA,NA,NA,"2013","06","Alessandra Solari","AS",14,TRUE,5,10,6,5,TRUE,TRUE,FALSE,0,NA,FALSE
